Cargando…
Unmet Clinical Needs and Management Recommendations for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Consensus-based Position Paper From an Ad Hoc International Expert Panel
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a hematological malignancy characterized by recurrent skin nodules, an aggressive clinical course with rapid involvement of hematological organs, and a poor prognosis with overall survival. The rarity of the disease results in a few large-scale...
Autores principales: | Pagano, Livio, Zinzani, Pier Luigi, Pileri, Stefano, Quaglino, Pietro, Cuglievan, Branko, Berti, Emilio, Pemmaraju, Naveen, Onida, Francesco, Willemze, Rein, Orfao, Alberto, Barosi, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946418/ https://www.ncbi.nlm.nih.gov/pubmed/36844178 http://dx.doi.org/10.1097/HS9.0000000000000841 |
Ejemplares similares
-
Recent developments in the treatment of blastic plasmacytoid dendritic cell neoplasm
por: Economides, Minas P., et al.
Publicado: (2019) -
Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects
por: Sapienza, Maria Rosaria, et al.
Publicado: (2019) -
Unmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus-based Position Paper From an ad hoc Expert Panel
por: Zinzani, Pier Luigi, et al.
Publicado: (2023) -
Therapeutic Approaches for Blastic Plasmacytoid Dendritic Cell Neoplasm: Allogeneic Hematopoietic Cell Transplantation and Novel Therapies
por: Kharfan-Dabaja, Mohamed A., et al.
Publicado: (2019) -
Whole‐genome analysis uncovers recurrent IKZF1 inactivation and aberrant cell adhesion in blastic plasmacytoid dendritic cell neoplasm
por: Bastidas Torres, Armando N., et al.
Publicado: (2019)